CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy

Prog Clin Biol Res. 1994:389:303-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / metabolism*
  • Antigens, CD34
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Breast Neoplasms / blood
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / therapy*
  • Cell Count
  • Colony-Forming Units Assay
  • Combined Modality Therapy
  • Female
  • Granulocytes
  • Hematopoiesis
  • Hematopoietic Stem Cell Transplantation*
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / drug effects*
  • Hematopoietic Stem Cells / immunology*
  • Humans
  • Leukocyte Count
  • Platelet Count
  • Transplantation, Autologous

Substances

  • Antigens, CD
  • Antigens, CD34
  • Antineoplastic Agents